Nicola Alexander Hanania

Nicola Alexander Hanania, M.D., M.S., is a Professor in the Department of Medicine at Baylor College of Medicine, Houston, Texas. He serves as Director of the Airways Clinical Research Center and Chief of Pulmonary/Critical Care/Sleep Medicine at Ben Taub Hospital. He is also Editor-in-Chief of Respiratory Medicine and Associate Editor for the asthma section of Current Opinion in Pulmonary Medicine.

• MBBS, University of Jordan (1984)
• Internal Medicine Residency, University of Jordan
• Pulmonary & Critical Care Residency, University of Toronto
• MSc in Clinical Investigations, Baylor College of Medicine (2010)

Dr. Hanania is a leading expert in asthma and COPD, with a research focus on airway pharmacology, clinical trials, and precision therapy. His work bridges translational science and clinical application, aiming to develop new treatments for chronic respiratory diseases. His interests include bronchodilators, biomarkers, and the role of biologics in severe asthma and COPD.

His recent publications reflect a strong trend in evaluating biologic therapies such as dupilumab and tezepelumab for COPD and asthma, understanding inflammatory phenotypes, and refining diagnostic tools like FeNO. He has led and contributed to numerous clinical trials and consensus guidelines in respiratory medicine.

Scientific Awards and Honors:

• Fellow of European Respiratory Society (FERS)
• Thomas Petty, MD, Master ACCP Memorial Lectureship in COPD
• Distinguished Scholar in Respiratory Health (ACCP)
• Career Investigator Award (K23), NIH/NHLBI
• Fulbright and Jaworski Faculty Excellence Award for Teaching (Baylor)
• Multiple teaching and humanitarian awards
• Listed in Marquis Who's Who in America

Dr. Hanania has received research funding from the American Lung Association, NIH, and industry sponsors. He leads a large research team involved in multi-center collaborative trials. He is actively involved in mentoring and faculty development, having been a member of the Academy of Distinguished Educators at Baylor College of Medicine.

He oversees the Airways Clinical Research Center, which conducts single- and multi-center clinical trials focused on asthma and COPD. The center is a hub for translational research and innovation in respiratory therapeutics.